Concepedia

Kai Hoehlig

KH

Statistics

Publications

16

Citations

2.3K

H-Index

14

Active since

2007

Affiliations

Noxxon Pharma (Germany)(Current)

University of Edinburgh

German Rheumatism Research Centre

Aptar (Germany)

Ludwig-Maximilians-Universität München

Kai Hoehlig is an author at Noxxon Pharma (Germany) specializing in medicine, immunology, and immune regulation.

ORCID

Top concepts

Publications per year

2007–2025

16

Publications

16

IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

Ping Shen, Toralf Roch, Vicky Lampropoulou et al. · Nature · 2014 · 995 citations · Full text

, , +10

TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity

Vicky Lampropoulou, Kai Hoehlig, Toralf Roch et al. · The Journal of Immunology · 2008 · 418 citations

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis

Daniel Ajona, Sergio Ortiz‐Espinosa, Haritz Moreno et al. · Cancer Discovery · 2017 · 247 citations

Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade

Dirk Zboralski, Kai Hoehlig, Dirk Eulberg et al. · Cancer Immunology Research · 2017 · 158 citations

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

Sergio Ortiz‐Espinosa, Xabier Morales, Yaiza Senent et al. · Cancer Letters · 2021 · 107 citations

, , +10

1–5 of 16